• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX27515X
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problems Atrial Fibrillation (1729); Cardiomyopathy (1764); Chest Pain (1776); Pneumonia (2011); Thrombus (2101); Ventricular Fibrillation (2130); Abdominal Distention (2601)
Event Date 06/11/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Patient presented with acute central chest pain, with severe intensity and anterolateral st elevation.Pci was performed to treat a 100% mid occlusion lesion in the lad.There was small diagonal 2 branch at the point of occlusion in the mid lad.The lesion was pre-dilated four times (10 atm, 12 atm, 12 atm, 8 atm) using a 2.5x15 mm euphora rx balloon.Two resolute onyx rx coronary drug eluting stents (2.75x18 mm and 2.5x15 mm) were overlapped and deployed in the lad.The 2.75x18 mm device was deployed at 15 atm.The stents were post-dilated to high pressure using a 3.0x12 mm balloon.A very good angiographic result was achieved after intra coronary verapamil boluses was performed to treat slow/ no flow in the distal lad.Patient was prescribed dapt for one year and nuseal aspirin for life along with betablocker and statin.After the patient had been discharged from the ccu it was reported that stent thrombosis and distal malapposition occurred in the lad.Recanalisation was performed in the cath lab.The patient suffered multiple further ventricular fibrillation arrests in the following days which required cpr and defibrillation.A temporary pacing wire was inserted.The patient developed hospital acquired pneumonia while they were in the icu and this was treated with antibiotics.Approximately seven days after admission the patient had abdominal distention due to ischaemic colitis and a further ventricular fibrillation occurred.An externalised pacemaker was inserted and later extubated and the patient was moved to the ccu.An icd (implantable cardioverter defibrillator) was inserted two weeks prior to discharge.Patient also developed myopathy and atrial fibrillation.The patient was discharged from the hospital on a later date.
 
Manufacturer Narrative
Correction: event date was (b)(6) second resolute onyx was ronyx27515x additional information: patient presented with acute central chest pain, with severe intensity and anterolateral st elevation.Pci was performed to treat a 100% mid occlusion lesion in the lad.Access was through the right radial artery 6fr.There was small diagonal 2 branch at the point of occlusion in the mid lad.There was diffuse distal disease in the distal lad.The lesion was pre-dilated four times (10 atm, 12 atm, 12 atm, 8 atm) using a 2.5x15 mm euphora rx balloon.Two resolute onyx rx coronary drug eluting stents (2.75x18 mm and 2.75x15 mm) were overlapped and deployed in the lad.The 2.75x18 mm device was deployed at 15 atm.The 2.75x15mm resolute onyx was deployed at 12atm at 47 seconds, and 14 atm at 7 seconds.The stents were post-dilated to high pressure using a 3.0x12 mm nc balloon.A very good angiographic result was achieved after intra-coronary verapamil boluses was performed to treat some slow/no flow in the distal lad.Patient was prescribed dapt for one year and nuseal aspirin for life along with betablocker and statin.Patient presented one day after seven days post discharge from the ccu with chest pain followed by collapse at home.The patient received chest compressions and 2 shocks by paramedics due to ventricular fibrillation.The patient was brought to the cath lab and it was reported that stent thrombosis and distal malposition had occurred in the lad.Pci/recanalisation was performed in the cath lab.A resolute onyx stent was used and a non-medtronic balloon.The patient was intubated and ventilated in icu with vasopressor support following recanalisation in cath lab.The patient suffered multiple further ventricular fibrillation arrests in the following days which required cpr and defibrillation.A temporary pacing wire was inserted.The patient developed hospital acquired pneumonia and this was treated with antibiotics.Approximately seven days after admission the patient had abdominal distention due to ischaemic colitis and a further ventricular fibrillation occurred.Subtotal colectomy was performed for the ischaemic bowel.Gram negative septicaemia was treated with antibiotics.An externalised pacemaker was inserted and later extubated and the patient was moved to the ccu.Patient also developed icu myopathy, atrial fibrillation, anuric kidney injury of unknown cause and a urinary tract infection.An icd (implantable cardioverter defibrillator) was inserted two weeks prior to discharge.The patient was discharged from the hospital on a later date.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Event date.The event occurred approx one week post implant ((b)(6) 2018) of the two resolute onyx stents.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8027618
MDR Text Key125761108
Report Number9612164-2018-03017
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/11/2020
Device Catalogue NumberRONYX27515X
Device Lot Number0009029951
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2018
Date Device Manufactured03/12/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient Weight77
-
-